May 13th 2025
This FDA decision will help to improve clarity and diagnostic accuracy of echocardiograms in pediatric patients, according to GE HealthCare.
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Pediatric cancer survivors and cardiovascular toxicity, disease risk
March 21st 2025Pediatric cancer survivors can be vulnerable to cardiovascular disease in the short- or long-term with increased recognition of cardiotoxic cancer treatments, as 5-year survival rates for children are greater than 85%.
Study finds Black infants with heart abnormalities more likely to die within first year
September 27th 2024A study presented at the AAP 2024 National Conference & Exhibition finds Black infants are 40% more likely to die from congenital heart disease than White infants, highlighting persistent racial health disparities.
Can smartwatch technology identify arrhythmias in children with adult algorithms?
February 28th 2024Scott Ceresnak, MD, explains smartwatch technology could be a great tool in detecting arrhythmias in children, however, given that algorithms in the technology were designed for adults, caution must be used as well.
Life-course approach, starting in infancy, can reduce risk of cardiovascular disease
December 11th 2023In a study that measured blood pressure (BP) in multiple stages of life until young adulthood, investigators concluded that lower BP levels early in life, maintained through young adulthood, could reduce the risk of cardiovascular disease (CVD).
Oral vs intravenous acetaminophen: Which is better for closing a patent ductus arteriosus?
August 2nd 2023In the 18 studies that assessed the efficacy of closing a patent ductus arteriosus after 1 course of acetaminophen treatments, the results demonstrated that both oral and IV preparations were more effective than placebo.
ADHD medications do not significantly increase cardiovascular disease risk
January 16th 2023A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.